Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
This report elaborates on the current development of the RNAi for Therapeutic Consumption industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
RXi Pharmaceuticals
miRagen Therapeutics
Quark Pharmaceuticals
Gradalis
Alnylam Pharmaceuticals
Arrowhead
Mirna Therapeutics
Sirnaomics
By Type:
siRNA
shRNA
miRNA
By Application:
Cardiovascular
HBV
Other
Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China RNAi for Therapeutic Consumption Market Overview 2018-2029
-
1.1 China RNAi for Therapeutic Consumption Industry Development Overview
-
1.2 China RNAi for Therapeutic Consumption Industry Development History
-
1.3 China RNAi for Therapeutic Consumption Industry Market Size (2018-2029)
-
1.4 China RNAi for Therapeutic Consumption Market Analysis by Type from Production Side
-
1.4.1 China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of siRNA (2018-2029)
-
1.4.2 China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of shRNA (2018-2029)
-
1.4.3 China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of miRNA (2018-2029)
-
1.5 China RNAi for Therapeutic Consumption Market Analysis by Application from Consumption End
-
1.5.1 China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
1.5.2 China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of HBV (2018-2029)
-
1.5.3 China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.4 China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.6 China RNAi for Therapeutic Consumption Market Analysis by Region
-
1.6.1 North China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.3 South China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.4 East China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
Chapter 2 China RNAi for Therapeutic Consumption Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on RNAi for Therapeutic Consumption Market Status and Competition at home and abroad in 2023
-
2.2.2 China RNAi for Therapeutic Consumption Market Status and Competition Analysis in 2023
-
2.2.3 China RNAi for Therapeutic Consumption Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China RNAi for Therapeutic Consumption Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on RNAi for Therapeutic Consumption Industry Development
Chapter 3 RNAi for Therapeutic ConsumptionIndustry Chain Analysis
-
3.1 RNAi for Therapeutic Consumption Industry Chain
-
3.2 RNAi for Therapeutic Consumption Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the RNAi for Therapeutic Consumption Market
-
3.3 RNAi for Therapeutic Consumption Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the RNAi for Therapeutic Consumption Market
Chapter 4 China RNAi for Therapeutic Consumption Market, by Type
-
4.1 China RNAi for Therapeutic Consumption Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China RNAi for Therapeutic Consumption Total Production Volume and Growth Rate from Production Side
-
4.5 China RNAi for Therapeutic Consumption Production Volume and Growth Rate, by Type
-
4.5.1 China RNAi for Therapeutic Consumption Production Volume and Growth Rate of siRNA
-
4.5.2 China RNAi for Therapeutic Consumption Production Volume and Growth Rate of shRNA
-
4.5.3 China RNAi for Therapeutic Consumption Production Volume and Growth Rate of miRNA
Chapter 5 China RNAi for Therapeutic Consumption Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China RNAi for Therapeutic Consumption Total Market Size and Growth Rate from Consumption End
-
5.5 China RNAi for Therapeutic Consumption Market Size and Growth Rate, by Application
-
5.5.1 China RNAi for Therapeutic Consumption Market Size and Growth Rate of Cardiovascular
-
5.5.2 China RNAi for Therapeutic Consumption Market Size and Growth Rate of HBV
-
5.5.3 China RNAi for Therapeutic Consumption Market Size and Growth Rate of Other
-
5.5.4 China RNAi for Therapeutic Consumption Market Size and Growth Rate of Cancer
Chapter 6 China RNAi for Therapeutic Consumption Market, by Region
-
6.1 China RNAi for Therapeutic Consumption Production Volume and Production Value, by Region
-
6.2 China RNAi for Therapeutic Consumption Sales Volume and Sales Value, by Region
Chapter 7 North China RNAi for Therapeutic Consumption Market Analysis
-
7.1 North China RNAi for Therapeutic Consumption Market, by Type
-
7.2 North China RNAi for Therapeutic Consumption Market, by Application
Chapter 8 Central China RNAi for Therapeutic Consumption Market Analysis
-
8.1 Central China RNAi for Therapeutic Consumption Market, by Type
-
8.2 Central China RNAi for Therapeutic Consumption Market, by Application
Chapter 9 South China RNAi for Therapeutic Consumption Market Analysis
-
9.1 South China RNAi for Therapeutic Consumption Market, by Type
-
9.2 South China RNAi for Therapeutic Consumption Market, by Application
Chapter 10 East China RNAi for Therapeutic Consumption Market Analysis
-
10.1 East China RNAi for Therapeutic Consumption Market, by Type
-
10.2 East China RNAi for Therapeutic Consumption Market, by Application
Chapter 11 Northeast China RNAi for Therapeutic Consumption Market Analysis
-
11.1 Northeast China RNAi for Therapeutic Consumption Market, by Type
-
11.2 Northeast China RNAi for Therapeutic Consumption Market, by Application
Chapter 12 Southwest China RNAi for Therapeutic Consumption Market Analysis
-
12.1 Southwest China RNAi for Therapeutic Consumption Market, by Type
-
12.2 Southwest China RNAi for Therapeutic Consumption Market, by Application
Chapter 13 Northwest China RNAi for Therapeutic Consumption Market Analysis
-
13.1 Northwest China RNAi for Therapeutic Consumption Market, by Type
-
13.2 Northwest China RNAi for Therapeutic Consumption Market, by Application
Chapter 14 Company Profiles
-
14.1 RXi Pharmaceuticals
-
14.1.1 RXi Pharmaceuticals Company Profile
-
14.1.2 RXi Pharmaceuticals RNAi for Therapeutic Consumption Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 miRagen Therapeutics
-
14.2.1 miRagen Therapeutics Company Profile
-
14.2.2 miRagen Therapeutics RNAi for Therapeutic Consumption Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Quark Pharmaceuticals
-
14.3.1 Quark Pharmaceuticals Company Profile
-
14.3.2 Quark Pharmaceuticals RNAi for Therapeutic Consumption Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Gradalis
-
14.4.1 Gradalis Company Profile
-
14.4.2 Gradalis RNAi for Therapeutic Consumption Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Alnylam Pharmaceuticals
-
14.5.1 Alnylam Pharmaceuticals Company Profile
-
14.5.2 Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Arrowhead
-
14.6.1 Arrowhead Company Profile
-
14.6.2 Arrowhead RNAi for Therapeutic Consumption Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Mirna Therapeutics
-
14.7.1 Mirna Therapeutics Company Profile
-
14.7.2 Mirna Therapeutics RNAi for Therapeutic Consumption Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sirnaomics
-
14.8.1 Sirnaomics Company Profile
-
14.8.2 Sirnaomics RNAi for Therapeutic Consumption Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 RNAi for Therapeutic Consumption Industry Research Conclusions
-
15.2 RNAi for Therapeutic Consumption Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China RNAi for Therapeutic Consumption Industry Market Size (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of siRNA (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of shRNA (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Production Volume, Production Value and Growth Rate of miRNA (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Cardiovascular (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of HBV (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China RNAi for Therapeutic Consumption Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure North China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure Central China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure South China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure East China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure Northeast China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure Southwest China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure Northwest China RNAi for Therapeutic Consumption Market Size and Growth Rate from 2018-2029
-
Figure RNAi for Therapeutic Consumption Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China RNAi for Therapeutic Consumption Market Share by Type in 2018
-
Figure China RNAi for Therapeutic Consumption Market Share by Type in 2023
-
Figure China RNAi for Therapeutic Consumption Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Production Volume and Growth Rate of siRNA (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Production Volume and Growth Rate of shRNA (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Production Volume and Growth Rate of miRNA (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Market Share by Application in 2018
-
Figure China RNAi for Therapeutic Consumption Market Share by Application in 2023
-
Figure China RNAi for Therapeutic Consumption Total Market Size and Growth Rate from Consumption End
-
Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate of Cardiovascular (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate of HBV (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate of Other (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Market Size and Growth Rate of Cancer (2018-2023)
-
Table China RNAi for Therapeutic Consumption Production Volume by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Production Volume Share by Region (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Production Volume Share by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Production Value by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Production Value Share by Region (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Production Value Share by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Sales Volume by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Sales Volume Share by Region (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Sales Volume Share by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Sales Value by Region (2018-2023)
-
Table China RNAi for Therapeutic Consumption Sales Value Share by Region (2018-2023)
-
Figure China RNAi for Therapeutic Consumption Sales Value Share by Region (2018-2023)
-
Table North China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table North China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure North China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table North China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table North China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure North China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table Central China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table Central China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure Central China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table Central China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table Central China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure Central China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table South China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table South China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure South China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table South China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table South China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure South China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table East China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table East China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure East China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table East China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table East China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure East China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table Northeast China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table Northeast China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure Northeast China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table Northeast China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table Northeast China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure Northeast China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table Southwest China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table Southwest China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure Southwest China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table Southwest China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table Southwest China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure Southwest China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table Northwest China RNAi for Therapeutic Consumption Production Volume by Type (2018-2023)
-
Table Northwest China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Figure Northwest China RNAi for Therapeutic Consumption Production Volume Share by Type (2018-2023)
-
Table Northwest China RNAi for Therapeutic Consumption Sales Volume by Application (2018-2023)
-
Table Northwest China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Figure Northwest China RNAi for Therapeutic Consumption Sales Volume Share by Application (2018-2023)
-
Table RXi Pharmaceuticals Company Profile
-
Table RXi Pharmaceuticals RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table miRagen Therapeutics Company Profile
-
Table miRagen Therapeutics RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Quark Pharmaceuticals Company Profile
-
Table Quark Pharmaceuticals RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Gradalis Company Profile
-
Table Gradalis RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals Company Profile
-
Table Alnylam Pharmaceuticals RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Arrowhead Company Profile
-
Table Arrowhead RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Mirna Therapeutics Company Profile
-
Table Mirna Therapeutics RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
Table Sirnaomics Company Profile
-
Table Sirnaomics RNAi for Therapeutic Consumption Revenue, Price and Gross (2018-2023)
-
